Mid West One Financial Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Mid West One Financial Group, Inc.
- $803 Million
- Q3 2025
A detailed history of Mid West One Financial Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mid West One Financial Group, Inc. holds 1,097 shares of REGN stock, worth $760,769. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,097
Previous 389
182.01%
Holding current value
$760,769
Previous $204,000
201.96%
% of portfolio
0.08%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
86.4MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...